Top compounds associated with response to DRD5


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.065 0.06
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.06
mRNA Merck60 CTRPv2 pan-cancer AAC 0.055 0.06
mRNA BRD-K41597374 CTRPv2 pan-cancer AAC 0.064 0.06
mRNA CD-437 CTRPv2 pan-cancer AAC 0.058 0.07
mRNA XMD14-99 GDSC1000 pan-cancer AAC 0.059 0.07
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.059 0.07
mRNA Gemcitabine gCSI pan-cancer AAC -0.098 0.07
mRNA Methotrexate FIMM pan-cancer AAC -0.24 0.07
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.055 0.07
Download CSV